156 related articles for article (PubMed ID: 16830881)
1. Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant.
Nagasawa K; Tada Y; Koarada S; Tsukamoto H; Horiuchi T; Yoshizawa S; Murai K; Ueda A; Haruta Y; Ohta A
Lupus; 2006; 15(6):354-7. PubMed ID: 16830881
[TBL] [Abstract][Full Text] [Related]
2. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI.
Nagasawa K; Tada Y; Koarada S; Horiuchi T; Tsukamoto H; Murai K; Ueda A; Yoshizawa S; Ohta A
Lupus; 2005; 14(5):385-90. PubMed ID: 15934439
[TBL] [Abstract][Full Text] [Related]
3. MDR1(ABCB1) gene polymorphisms associated with steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus.
Yang XY; Xu DH
Pharmazie; 2007 Dec; 62(12):930-2. PubMed ID: 18214345
[TBL] [Abstract][Full Text] [Related]
4. High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus.
Kuroda T; Tanabe N; Wakamatsu A; Takai C; Sato H; Nakatsue T; Wada Y; Nakano M; Narita I
Clin Rheumatol; 2015 Dec; 34(12):2071-7. PubMed ID: 26384821
[TBL] [Abstract][Full Text] [Related]
5. Prognostication of osteonecrosis of the femoral head in patients with systemic lupus erythematosus by magnetic resonance imaging.
Sugano N; Ohzono K; Masuhara K; Takaoka K; Ono K
Clin Orthop Relat Res; 1994 Aug; (305):190-9. PubMed ID: 8050228
[TBL] [Abstract][Full Text] [Related]
6. High risk of osteonecrosis of the femoral head in autoimmune disease patients showing no immediate increase in hepatic enzyme under steroid therapy.
Okazaki S; Nagoya S; Yamamoto M; Tateda K; Takahashi H; Yamashita T; Matsumoto H
Rheumatol Int; 2013 Jan; 33(1):51-5. PubMed ID: 22215042
[TBL] [Abstract][Full Text] [Related]
7. Asymptomatic avascular osteonecrosis of the hip in new patients diagnosed as systemic lupus erythematosus in Ramathibodi Hospital.
Jaovisidha S; Denprechawong R; Suwannalai P; Janwityanujit S
J Med Assoc Thai; 2007 Jul; 90(7):1382-90. PubMed ID: 17710981
[TBL] [Abstract][Full Text] [Related]
8. Core decompression for osteonecrosis of the femoral head in systemic lupus erythematosus.
Mont MA; Fairbank AC; Petri M; Hungerford DS
Clin Orthop Relat Res; 1997 Jan; (334):91-7. PubMed ID: 9005900
[TBL] [Abstract][Full Text] [Related]
9. [Clinical condition of steroid-induced osteonecrosis of the femoral head].
Kubo T; Fujioka M; Ishida M
Clin Calcium; 2007 Jun; 17(6):856-62. PubMed ID: 17548924
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?
Rascu A; Manger K; Kraetsch HG; Kalden JR; Manger B
Lupus; 1996 Aug; 5(4):323-7. PubMed ID: 8869906
[TBL] [Abstract][Full Text] [Related]
11. ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation.
Asano T; Takahashi KA; Fujioka M; Inoue S; Okamoto M; Sugioka N; Nishino H; Tanaka T; Hirota Y; Kubo T
Pharmacogenetics; 2003 Nov; 13(11):675-82. PubMed ID: 14583680
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of femoral head in SLE patient after short period of corticosteroid therapy--a case report.
Memon S; Rab SM
J Pak Med Assoc; 1991 Aug; 41(8):197-8. PubMed ID: 1942485
[No Abstract] [Full Text] [Related]
13. Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy.
Ono K; Tohjima T; Komazawa T
Clin Orthop Relat Res; 1992 Apr; (277):89-97. PubMed ID: 1555361
[TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis of the femoral head that developed after long-term topical steroid application.
Kubo T; Kojima A; Yamazoe S; Ueshima K; Yamamoto T; Hirasawa Y
J Orthop Sci; 2001; 6(1):92-4. PubMed ID: 11289593
[TBL] [Abstract][Full Text] [Related]
15. Age at time of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus: a prospective magnetic resonance imaging study.
Nakamura J; Saisu T; Yamashita K; Suzuki C; Kamegaya M; Takahashi K
Arthritis Rheum; 2010 Feb; 62(2):609-15. PubMed ID: 20112393
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment.
Oinuma K; Harada Y; Nawata Y; Takabayashi K; Abe I; Kamikawa K; Moriya H
Ann Rheum Dis; 2001 Dec; 60(12):1145-8. PubMed ID: 11709458
[TBL] [Abstract][Full Text] [Related]
17. Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study.
Long Y; Zhang S; Zhao J; You H; Zhang L; Li J; Leng X; Wang Q; Tian X; Li M; Zeng X
Lupus; 2021 Aug; 30(9):1459-1468. PubMed ID: 34082592
[TBL] [Abstract][Full Text] [Related]
18. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment.
Koo KH; Kim R; Kim YS; Ahn IO; Cho SH; Song HR; Park YS; Kim H; Wang GJ
Clin Rheumatol; 2002 Aug; 21(4):299-303. PubMed ID: 12189457
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight phenotype of Apo(a) is a risk factor of corticosteroid-induced osteonecrosis of the femoral head after renal transplant.
Hirata T; Fujioka M; Takahashi KA; Asano T; Ishida M; Akioka K; Okamoto M; Yoshimura N; Satomi Y; Nishino H; Hirota Y; Nakajima S; Kato S; Kubo T
J Rheumatol; 2007 Mar; 34(3):516-22. PubMed ID: 17143965
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
Tanaka Y; Yoshikawa N; Hattori S; Sasaki S; Ando T; Ikeda M; Honda M;
Pediatr Nephrol; 2010 May; 25(5):877-82. PubMed ID: 19902267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
